Behavioral Health Business March 18, 2024
More startups are seeking Food and Drug Administration (FDA) clearance for autism spectrum disorders interventions beyond behavior therapies.
While widely varied in type and approach, these companies seek to bring the scientific rigor and scrutiny that is more of a type with medical devices. The FDA clearance process provides something tantamount to a permission slip to bring new services to bear on health conditions. In so doing, these device companies seek to help address some of the most difficult issues facing the industry, namely the subjectivity of autism diagnosis and treatment, the time it takes to conduct diagnoses and even treat some symptoms of autism.
Companies that go this route have a tough road to walk. A survey of device...
Today's Sponsors
Today's Sponsor